Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP667713.RA8TgydktFDyQEQRgiQnw-BUcpbKLfjl5jTbtyPRd0XxQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP667713.RA8TgydktFDyQEQRgiQnw-BUcpbKLfjl5jTbtyPRd0XxQ130_assertion type Assertion NP667713.RA8TgydktFDyQEQRgiQnw-BUcpbKLfjl5jTbtyPRd0XxQ130_head.
- NP667713.RA8TgydktFDyQEQRgiQnw-BUcpbKLfjl5jTbtyPRd0XxQ130_assertion description "[Increased activity of PDE5 (and perhaps also PDE9) in glomeruli and in cells of collecting ducts in sodium-retaining states, such as nephrotic syndrome, accounts for renal resistance to atriopeptin; diminished ability to excrete sodium can be corrected by administration of the selective PDE5 inhibitor zaprinast.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP667713.RA8TgydktFDyQEQRgiQnw-BUcpbKLfjl5jTbtyPRd0XxQ130_provenance.
- NP667713.RA8TgydktFDyQEQRgiQnw-BUcpbKLfjl5jTbtyPRd0XxQ130_assertion evidence source_evidence_literature NP667713.RA8TgydktFDyQEQRgiQnw-BUcpbKLfjl5jTbtyPRd0XxQ130_provenance.
- NP667713.RA8TgydktFDyQEQRgiQnw-BUcpbKLfjl5jTbtyPRd0XxQ130_assertion SIO_000772 9893113 NP667713.RA8TgydktFDyQEQRgiQnw-BUcpbKLfjl5jTbtyPRd0XxQ130_provenance.
- NP667713.RA8TgydktFDyQEQRgiQnw-BUcpbKLfjl5jTbtyPRd0XxQ130_assertion wasDerivedFrom befree-20140225 NP667713.RA8TgydktFDyQEQRgiQnw-BUcpbKLfjl5jTbtyPRd0XxQ130_provenance.
- NP667713.RA8TgydktFDyQEQRgiQnw-BUcpbKLfjl5jTbtyPRd0XxQ130_assertion wasGeneratedBy ECO_0000203 NP667713.RA8TgydktFDyQEQRgiQnw-BUcpbKLfjl5jTbtyPRd0XxQ130_provenance.